Published Study Demonstrated Once-Daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII Provided Significant …
Published Study Demonstrated Once-Daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII Provided Significant …
Shire plc , the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse® Capsules CII demonstrated significant improvement in attention.  This improvement was measured by average of Permanent Product Measure of Performance total scores of …
Read more on PR Newswire via Yahoo! Finance
Rise and shine Brevard: It’s almost school time
Children and teens who’ve been staying up late and sleeping in this summer are in for a rude awakening.
Read more on Florida Today
Depression and Insomnia
Insomnia and depression often go hand-in-hand. Discover which insomnia treatment works best for depression.
Read more on WebMD
Categories: News Tags: capsules, Demonstrated, dimesylate, lisdexamfetamine, OnceDaily, Provided, Published, Significant, Study, Vyvanse®